These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2940091)

  • 1. QRS-amplitudes during antihypertensive treatment: a comparison between beta-blocker and thiazide diuretic regimens.
    Samuelsson O; Berglund G; Elmfeldt D; Wilhelmsen L; Wikstrand J
    Eur Heart J; 1986 Mar; 7(3):254-61. PubMed ID: 2940091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.
    Wikstrand J; Westergren G; Berglund G; Bracchetti D; Van Couter A; Feldstein CA; Ming KS; Kuramoto K; Landahl S; Meaney E
    JAMA; 1986 Mar; 255(10):1304-10. PubMed ID: 3511308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.
    Eliasson K; Kahan T; Hylander B; Hjemdahl P
    Br J Clin Pharmacol; 1987 Jul; 24(1):1-14. PubMed ID: 2887186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study.
    Olsson G; Tuomilehto J; Berglund G; Elmfeldt D; Warnold I; Barber H; Eliasson K; Jastrup B; Karatzas N; Leer J
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):151-8. PubMed ID: 2021446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
    Dafgärd T; Forsén B; Lindahl T
    Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention in patients with hypertension: comments on the clinical implications of the MAPHY Study. Metoprolol Atherosclerosis Prevention in Hypertensives Study.
    Wikstrand J
    Am Heart J; 1988 Jul; 116(1 Pt 2):338-47. PubMed ID: 3293400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the antihypertensive effect of metoprolol in combination with hydrochlorothiazide and hydralazine in an unselected hypertensive population.
    Tuomilehto J; Nissinen A; Honkavaara M
    Acta Cardiol; 1980; 35(4):289-301. PubMed ID: 7010854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metoprolol on blood pressure and plasma renin activity in thiazide-resistant hypertensive patients.
    Velasquez MT; Han Wan S; Maronde RF
    Clin Pharmacol Ther; 1979 Nov; 26(5):555-61. PubMed ID: 498696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents.
    Pedersen OL
    Eur J Clin Pharmacol; 1976; 10(6):381-5. PubMed ID: 793849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.
    Wikstrand J; Warnold I; Olsson G; Tuomilehto J; Elmfeldt D; Berglund G
    JAMA; 1988 Apr; 259(13):1976-82. PubMed ID: 3346979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 16. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity to mental stress and cold provocation during long-term treatment with metoprolol, propranolol or hydrochlorothiazide.
    Eliasson K; Kahan T; Hylander B; Hjemdahl P
    J Hypertens Suppl; 1986 Dec; 4(6):S263-5. PubMed ID: 3475414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does hormone analysis predict the antihypertensive response of basic medical treatment?
    Witzgall H; Scherer B; Lange HH; Weber PC
    Herz; 1989 Jun; 14(3):197-203. PubMed ID: 2661389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol or hydrochlorothiazide in patients with hypertension aged 60-75 years. With special reference to assessment of compliance. Hunter Hypertension Research Group.
    Med J Aust; 1986 Nov; 145(10):521-3. PubMed ID: 2877386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.